148 related articles for article (PubMed ID: 30782033)
21. Epigenetic Marks in Polycystic Ovary Syndrome.
Motta AB
Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
[TBL] [Abstract][Full Text] [Related]
22. Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome.
Mao Z; Li T; Zhao H; Wang X; Kang Y; Kang Y
J Cell Physiol; 2021 Sep; 236(9):6362-6375. PubMed ID: 33521992
[TBL] [Abstract][Full Text] [Related]
23. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
Cui P; Ma T; Tamadon A; Han S; Li B; Chen Z; An X; Shao LR; Wang Y; Feng Y
Exp Physiol; 2018 Dec; 103(12):1618-1632. PubMed ID: 30204276
[TBL] [Abstract][Full Text] [Related]
24. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.
Urbanek M; Sam S; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4191-8. PubMed ID: 17785364
[TBL] [Abstract][Full Text] [Related]
25. Deciphering the DNA Methylome of Polycystic Ovary Syndrome.
Tan Q
Mol Diagn Ther; 2020 Jun; 24(3):245-250. PubMed ID: 32297305
[TBL] [Abstract][Full Text] [Related]
26. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
Jiang LL; Xie JK; Cui JQ; Wei D; Yin BL; Zhang YN; Chen YH; Han X; Wang Q; Zhang CL
Medicine (Baltimore); 2017 Jan; 96(2):e5768. PubMed ID: 28079802
[TBL] [Abstract][Full Text] [Related]
27. LINE1 CpG-DNA Hypomethylation in Granulosa Cells and Blood Leukocytes Is Associated With PCOS and Related Traits.
Sagvekar P; Mangoli V; Desai S; Patil A; Mukherjee S
J Clin Endocrinol Metab; 2017 Apr; 102(4):1396-1405. PubMed ID: 28324041
[TBL] [Abstract][Full Text] [Related]
28. Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.
Dunaif A
J Clin Endocrinol Metab; 2016 Mar; 101(3):759-68. PubMed ID: 26908109
[TBL] [Abstract][Full Text] [Related]
29. Resistance and aerobic training increases genome-wide DNA methylation in women with polycystic ovary syndrome.
Miranda Furtado CL; Hansen M; Kogure GS; Ribeiro VB; Taylor N; Racy Soares M; Ferriani RA; Aston KI; Jenkins T; Dos Reis RM
Epigenetics; 2024 Dec; 19(1):2305082. PubMed ID: 38245873
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation in the pathogenesis of polycystic ovary syndrome.
Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
[TBL] [Abstract][Full Text] [Related]
31. Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome.
Knebel B; Lehr S; Janssen OE; Hahn S; Jacob S; Nitzgen U; Müller-Wieland D; Kotzka J
Mol Biol Rep; 2017 Feb; 44(1):51-61. PubMed ID: 27878529
[TBL] [Abstract][Full Text] [Related]
32. A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies.
Joo YY; Actkins K; Pacheco JA; Basile AO; Carroll R; Crosslin DR; Day F; Denny JC; Velez Edwards DR; Hakonarson H; Harley JB; Hebbring SJ; Ho K; Jarvik GP; Jones M; Karaderi T; Mentch FD; Meun C; Namjou B; Pendergrass S; Ritchie MD; Stanaway IB; Urbanek M; Walunas TL; Smith M; Chisholm RL; Kho AN; Davis L; Hayes MG;
J Clin Endocrinol Metab; 2020 Jun; 105(6):1918-36. PubMed ID: 31917831
[TBL] [Abstract][Full Text] [Related]
33. Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.
Zhao H; Xu X; Xing X; Wang J; He L; Shi Y; Shi Y; Zhao Y; Chen ZJ
Hum Reprod; 2012 Jan; 27(1):294-8. PubMed ID: 22081247
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic/circadian clocks and PCOS.
Vatier C; Christin-Maitre S
Hum Reprod; 2024 Jun; 39(6):1167-1175. PubMed ID: 38600622
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.
Chen ZJ; Zhao H; He L; Shi Y; Qin Y; Shi Y; Li Z; You L; Zhao J; Liu J; Liang X; Zhao X; Zhao J; Sun Y; Zhang B; Jiang H; Zhao D; Bian Y; Gao X; Geng L; Li Y; Zhu D; Sun X; Xu JE; Hao C; Ren CE; Zhang Y; Chen S; Zhang W; Yang A; Yan J; Li Y; Ma J; Zhao Y
Nat Genet; 2011 Jan; 43(1):55-9. PubMed ID: 21151128
[TBL] [Abstract][Full Text] [Related]
36. Association between single nucleotide polymorphisms, TGF-β1 promoter methylation, and polycystic ovary syndrome.
Gao M; Liu X; Gu H; Xu H; Zhong W; Wei X; Zhong X
BMC Pregnancy Childbirth; 2024 Jan; 24(1):5. PubMed ID: 38166771
[TBL] [Abstract][Full Text] [Related]
37. Role of genomic DNA methylation in PCOS pathogenesis: a systematic review and meta-analysis involving case-controlled clinical studies.
Rawat K; Sandhu A; Gautam V; Saha PK; Saha L
Mol Hum Reprod; 2022 Jul; 28(8):. PubMed ID: 35789386
[TBL] [Abstract][Full Text] [Related]
38. The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.
Li S; Zhu D; Duan H; Tan Q
Gynecol Endocrinol; 2016 Dec; 32(12):942-946. PubMed ID: 27425146
[TBL] [Abstract][Full Text] [Related]
39. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.
Strauss JF
Ann N Y Acad Sci; 2003 Nov; 997():42-8. PubMed ID: 14644808
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys.
Xu N; Kwon S; Abbott DH; Geller DH; Dumesic DA; Azziz R; Guo X; Goodarzi MO
PLoS One; 2011; 6(11):e27286. PubMed ID: 22076147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
